NasdaqGS - Nasdaq Real Time Price USD
Exelixis, Inc. (EXEL)
42.73
+0.32
+(0.75%)
As of 1:38:25 PM EDT. Market Open.
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
25.2
Environmental Risk Score
4.3
Social Risk Score
15.3
Governance Risk Score
5.6
ESG Risk Score for Peers
Name | Total ESG Risk score | E | S | G |
---|---|---|---|---|
APNHF ASPEN PHARMACARE HLDGS | 25 | 4 | 16 | 6 |
SAN.SW SAN.SW | 25 | 1 | 14 | 9 |
EXEL Exelixis, Inc. | 25 | 4 | 15 | 6 |
TEHN.F TEHN.F,0P0000EHGJ,0 | 25 | -- | -- | -- |
LYEL Lyell Immunopharma, Inc. | 25 | -- | -- | -- |
Controversy Level Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
ESG data provided by Sustainalytics, Inc. Last Updated on 5/2025
EXEL
Category Average
1 Low Controversy Level
None 4 Severe
1.0 EXEL
0.5 Category Average
Product Involvement Areas Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
Products and Activities | Significant Involvement |
---|---|
Alcoholic Beverages | No |
Adult Entertainment | No |
Gambling | No |
Tobacco Products | No |
Animal Testing | Yes |
Fur and Specialty Leather | No |
Controversial Weapons | No |
Small Arms | No |
Catholic Values | No |
GMO | No |
Military Contracting | No |
Pesticides | No |
Thermal Coal | No |
Palm Oil | No |
Related Tickers
ARGX argenx SE
579.61
+0.58%
ACAD ACADIA Pharmaceuticals Inc.
22.34
+1.43%
CPRX Catalyst Pharmaceuticals, Inc.
24.42
-0.49%
HALO Halozyme Therapeutics, Inc.
54.67
+0.44%
INCY Incyte Corporation
66.03
+1.69%
ALNY Alnylam Pharmaceuticals, Inc.
292.12
+2.30%
ADMA ADMA Biologics, Inc.
19.87
+1.85%
CORT Corcept Therapeutics Incorporated
77.52
-0.17%
BMRN BioMarin Pharmaceutical Inc.
58.38
+0.50%
VRTX Vertex Pharmaceuticals Incorporated
444.96
-0.03%